North Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$380K Sell
1,529
-25
-2% -$6.6K 0.27% 54
2026
Q2
$395K Buy
1,554
+25
+2% +$5.83K 0.3% 55
2026
Q1
$374K Hold
1,529
– – 0.32% 51
2025
Q4
$316K Sell
1,529
-37
-2% -$7.32K 0.27% 58
2025
Q3
$290K Buy
1,566
+121
+8% +$20.7K 0.22% 58
2025
Q2
$221K Sell
1,445
-12
-0.8% -$1.84K 0.19% 71
2025
Q1
$242K Buy
+1,457
New +$228K 0.23% 62

Other funds holding JNJ

North Capital's JNJ Position: Q3 2026 in Review

North Capital reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q3 2026, selling an estimated $6.6K and leaving 1,529 shares worth $380K. The position accounts for 0.27% of the portfolio, ranked #54.

North Capital first reported a position in JNJ in Q1 2025 and has held it in 7 quarters since. The position peaked at $395K in Q2 2026. 2,965 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • North Capital held 1,529 shares of Johnson & Johnson worth $380K as of Q3 2026.
  • North Capital sold 25 Johnson & Johnson shares in Q3 2026, an estimated $6.6K.
  • Johnson & Johnson made up 0.27% of North Capital's portfolio in Q3 2026, its #54 holding.
  • North Capital first reported a position in Johnson & Johnson in Q1 2025 and has held it in 7 quarters since.
  • North Capital's Johnson & Johnson position peaked at $395K in Q2 2026.
  • 2,965 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on North Capital's 13F filing for Q3 2026, filed 16 Oct 2026.